John Tagliamonte

John Tagliamonte has more than 20 years of experience in executive leadership with responsibility for business development, finance, commercial and business operations, strategic planning, and legal functions with established and emerging public and private life sciences companies. As the first Entrepreneur-in-Residence with MassBio, he is responsible for forward-looking program content across the organization, while helping to develop the next generation of biotech entrepreneurs. In addition to PhagePro, he also serves on the business advisory boards of oncology drug startups Pyramid, WntRx, and PercpTx. Previously he was Chief Business Officer of rare disease company Oxyrane and held various executive business leadership roles at Anchor Therapeutics, ImmunoGen, and Johnson & Johnson, as well as venture investing with Safeguard Scientifics. He began his career as a scientist at Dana-Farber Cancer Institute followed by global business unit management at Bio-Rad. John received his M.B.A. from Boston College and his B.S. in molecular biology from Tufts University.